Trials / Conditions / Rosai-Dorfman Disease
Rosai-Dorfman Disease
6 registered clinical trials studyying Rosai-Dorfman Disease — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease NCT07187167 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Histiocytic Disorder Follow-up Study NCT05915208 | University of Alabama at Birmingham | — |
| Recruiting | In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET NCT05093335 | Memorial Sloan Kettering Cancer Center | EARLY_Phase 1 |
| Unknown | Lenalidomide and Dexamethasone for Rosai-Dorfman Disease NCT04924647 | Peking Union Medical College Hospital | Phase 2 |
| Recruiting | Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders NCT04079179 | Carl Allen | Phase 2 |
| Unknown | Central China Rosai-Dorfman Disease Registry NCT05284942 | Tongji Hospital | Phase 4 |